Skip to main content

Advertisement

Log in

Ciprofloxacin in the treatment of infections caused by gentamicin-resistant gram-negative bacteria

  • Notes
  • Ciprofloxacin: Clinical Experience
  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. King, A., Shannon, K., Phillips, I.: The in vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin. Journal of Antimicrobial Chemotherapy 1985, 15: 551–558.

    PubMed  Google Scholar 

  2. Palton, W. N., Smith, G. N., Leyland, M. J., Geddes, A. M.: Multiply resistantSalmonella typhimurium septicaemia in an immunocompromised patient successfully treated with ciprofloxacin. Journal of Antimicrobial Chemotherapy 1985, 16: 667–669.

    PubMed  Google Scholar 

  3. Smith, J. T.: Mutational resistance to 4-quinolone antibacterial agents. European Journal of Clinical Microbiology 1984, 3: 347–350.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mehtar, S., Drabu, Y. & Blakemore, P. Ciprofloxacin in the treatment of infections caused by gentamicin-resistant gram-negative bacteria. Eur. J, Clin. Microbiol. 5, 248–251 (1986). https://doi.org/10.1007/BF02014001

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02014001

Keywords

Navigation